The health of women depends on the health of our planet. While the ongoing climate crisis affects the entire world, pervasive gender inequality magnifies its impact on women and girls. At Organon, we are working to implement environmentally friendly practices and long-term sustainability across our operations and across our industry’s value chain. These efforts help us contribute to positive change for women everywhere. Our cross-functional EHS Council and ESG Council are responsible for overseeing our environmental sustainability strategy and goals. The EHS Council focuses on the implementation of our programs and our progress toward our environmental sustainability goals, while the ESG Council focuses on external communications and reporting associated with environmental sustainability. Both bodies include senior management representatives from various parts of the organization.At Organon, we are working to help women and girls achieve their promise through better health. Health is at the root of sustainable development for 18 individuals, communities, and societies. In addition, gender equity is an important indicator and contributor of economic growth. Women’s health should be a priority everywhere in the world. We are working toward a better and healthier every day for every woman by bringing forward the innovations needed to support women’s health, expanding access to medicines and other products, and advancing equity inside and outside the company.At Organon, we aim to be a credible voice for women’s rights and gender equity. Doing so and operating our business effectively require that we uphold the highest levels of ethics and integrity across our operations. This effort begins with our Board of Directors, which oversees our rigorous approach to ethics and compliance. Our vision of a better and healthier every day for every woman includes a dedication to ethical marketing practices, as well as accurate and clear product labeling and a commitment to a sustainable, diverse supply chain that respects human rights. Our extensive information security and data privacy programs safeguard the privacy of our stakeholders, and we are transparent about our public policy activities and political contributions. We are committed to upholding the highest levels of ethics and integrity throughout our business. We currently have a highly capable Board of Directors with an exemplary mix of relevant skills and experience. In addition, it is one of the most diverse Boards of Directors in the healthcare industry. We aspire to maintain the expertise as well as the gender and racial diversity that characterizes our Board today.Organon is a pharmaceutical company specializing in women’s health and other therapeutic areas. Its pharmaceutical products contribute to its financial stability. Organon’s R&D efforts are directed toward developing innovative therapies in women’s health, biosimilars, and other therapeutic areas. Its research initiatives drive the introduction of new treatments and revenue growth.It takes all of us at Organon working together to create an ethical culture and ensure that we act with integrity in everything we do. Our Code of Conduct outlines our ethical expectations and commitment to integrity. The Code of Conduct helps us earn and ultimately keep the trust of our customers, investors, and partners, as well as the communities where we operate around the world. It represents the very core of our character as a company. The Office of Ethics & Compliance actively supports our commitment to the highest standards of ethics and compliance by facilitating behavior consistent with the Code of Conduct, and by fostering a culture that promotes the prevention, detection, and resolution of potential misconduct. Our Compliance professionals support our sales and marketing efforts worldwide.